Medical Condition News

RSS

Active with Asthma: Free event to teach children, families how to manage the disease

On Friday, August 13th, children between the ages of 6 and 14 will participate in the American Lung Association in Iowa's asthma education event at Principal Park. This program provides children the chance to experience outdoor fun in a medically-supervised environment while learning to understand and manage their asthma.

15 Jul 2010

Pre-clinical study results of EVP-0015962 presented at AAICAD 2010

EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2010 International Conference on Alzheimer's Disease results from its proprietary gamma-secretase modulator pre-clinical study. In a transgenic mouse model, EnVivo's EVP-0015962 reduced amyloid plaque buildup which is believed to be a cause of Alzheimer's disease, reversed behavioral deficits and reduced brain inflammation associated with Alzheimer's disease.

15 Jul 2010

Long-term exposure of arsenic may increase risk for lung cancer

To determine how arsenic increases the risk of lung cancer and to identify potential treatments, a Michigan State University researcher will use $1.7 million in federal funding during the next five years to examine why certain genes disrupt cells, leading to the disease.

15 Jul 2010

Kidney Cancer Canada applauds Ontario for granting coverage for RCC therapy TORISEL

Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.

15 Jul 2010

Justice Department announces settlement agreement to improve access for persons with disabilities

The Justice Department today announced a settlement agreement with the city of Milton, Wash., under the Americans with Disabilities Act to improve access to city parks and recreational activities for persons with disabilities. The agreement resolves a complaint alleging that the city's parks and annual parade and festival are not accessible to individuals with mobility disabilities.

15 Jul 2010

Exposure to 9/11 can impact PTSD, depression levels among children

Two new longitudinal studies show that age played an important role in the effects of the September 11, 2001 (9/11) terrorist attacks on New York City. Both studies appear in a special section on children and disaster in the July/August 2010 issue of the journal Child Development. In the first study, researchers found higher rates of clinically significant behavior problems among preschool children directly exposed to 9/11 in Lower Manhattan according to whether their mothers had post-traumatic stress disorder (PTSD) and depression. In the second study, New York City adolescents and their mothers had generally elevated rates of PTSD and depression one year after 9/11. Direct exposure to the events of 9/11 played a small but significant role in explaining the severity of mental health symptoms.

15 Jul 2010

Obese people prefer non-commercial, non-stigmatizing techniques for lifestyle-change interventions

Obese people support lifestyle-change interventions, rather than those that purely promote weight loss. Researchers writing in BioMed Central's open access journal BMC Public Health interviewed 142 obese people about their opinions on interventions ranging from gastric bands to legal regulation, finding that non-commercial, non-stigmatizing techniques were preferred.

15 Jul 2010

University of Louisville ophthalmology professor receives $60,000 RPB Special Scholar Award

Qingxian Lu, PhD, assistant professor of ophthalmology and visual sciences at the University of Louisville School of Medicine, has received the $60,000 William and Mary Greve Special Scholar Award from the Research to Prevent Blindness (RPB) organization. The funds will go toward Lu's research in retinitis pigmentosa, a group of genetic disorders that can lead to night blindness, loss of peripheral vision and total blindness.

15 Jul 2010

Study reveals anti-diabetic properties of cashew seed extract

Cashew seed extract shows promise as an effective anti-diabetic, according to a new study from the University of Montreal (Canada) and the Universit- de Yaound- (Cameroun). Published in the journal Molecular Nutrition & Food Research, the investigation analyzed the reputed health benefits of cashew tree products on diabetes, notably whether cashew extracts could improve the body's response to its own insulin.

15 Jul 2010

New myopia control technology for eye health benefits from Vision CRC

Scientists from the Vision Cooperative Research Centre in Australia have announced that myopia, or short-sightedness, can be controlled with new technology. This ground breaking discovery was based on research conducted by Vision CRC partners – the University of Houston College of Optometry and the Brien Holden Vision Institute, located at the University of New South Wales.

15 Jul 2010

Keck School of Medicine receives grant for research on biomarker impact on breast cancer screening

Researchers at the Keck School of Medicine of the University of Southern California (USC) will test whether a set of blood-based biomarkers can assist mammography in the early detection of breast cancer with a $180,000 grant announced today from Susan G. Komen for the Cure®. The grant will fund research into whether specific biomarkers, or minute substances in the blood, can effectively distinguish breast cancer patients from their healthy counterparts and whether an inexpensive, less invasive screening strategy can be developed based on this approach.

15 Jul 2010

Hospital for Special Surgery named top hospital for orthopedics

Hospital for Special Surgery has been named the top hospital in the nation for orthopedics by U.S. News & World Report in its 2010 "America's Best Hospitals" issue. Once again the hospital ranked as a leader in rheumatology at number 3 in the nation. In addition, neurology was ranked at number 16.

15 Jul 2010

GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market

GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.

15 Jul 2010

Study links obesity to poorer memory, brain function in older women

The more an older woman weighs, the worse her memory, according to new research from Northwestern Medicine. The effect is more pronounced in women who carry excess weight around their hips, known as pear shapes, than women who carry it around their waists, called apple shapes.

15 Jul 2010

Enrollment complete in Nabi's first NicVAX Phase III clinical trial for nicotine addiction

Nabi Biopharmaceuticals announced today that it has completed enrollment in the first Phase III clinical trial of NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary investigational vaccine being developed to treat nicotine addiction and prevent smoking relapse.

15 Jul 2010

Mylan subsidiary receives FDA final approval for Nabumetone Tablets ANDA

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nabumetone Tablets USP, 500 mg and 750 mg.

15 Jul 2010

KRX-0401 receives Orphan Drug designation from FDA for treatment of neuroblastoma

Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan Drug designation from the U.S. Food and Drug Administration for the treatment of neuroblastoma, a cancer of the nervous system affecting mostly children and infants for which there are no FDA approved therapies.

15 Jul 2010

SWCRF/Emerald Foundation Global Collaborative Grant to fund critical cancer research

The leukemia stem cell-the root cause of all acute leukemias- represents a small population of cells in patients that are difficult to eliminate with standard treatments available today. Though current chemotherapy can produce temporary remission in leukemia survivors, they remain at risk of experiencing a recurrence and dying from the disease.

15 Jul 2010

Concert Medical releases 'Conductor' family of Interventional Coronary Guidewires in U.S.

Concert Medical, LLC today announced the launch of the "Conductor™" family of Interventional Coronary Guidewires to the U.S. market. These guidewires are designed to address an extensive range of coronary disease cases at a superior value. The FDA granted Concert Medical clearance for the use and sale in the U.S. of the Conductor product line in September 2009.

15 Jul 2010

Research: Early diagnosis, care management for people with dementia can lower outpatient costs by 30%

Early detection, diagnosis and care management for people newly diagnosed with cognitive impairment and dementia reduces outpatient costs by almost 30 percent, according to new research reported today at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 in Honolulu.

15 Jul 2010

Medical Condition News

Active with Asthma: Free event to teach children, families how to manage the disease

Pre-clinical study results of EVP-0015962 presented at AAICAD 2010

Long-term exposure of arsenic may increase risk for lung cancer

Kidney Cancer Canada applauds Ontario for granting coverage for RCC therapy TORISEL

Justice Department announces settlement agreement to improve access for persons with disabilities

Exposure to 9/11 can impact PTSD, depression levels among children

Obese people prefer non-commercial, non-stigmatizing techniques for lifestyle-change interventions

University of Louisville ophthalmology professor receives $60,000 RPB Special Scholar Award

Study reveals anti-diabetic properties of cashew seed extract

New myopia control technology for eye health benefits from Vision CRC

Keck School of Medicine receives grant for research on biomarker impact on breast cancer screening

Hospital for Special Surgery named top hospital for orthopedics

GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market

Study links obesity to poorer memory, brain function in older women

Enrollment complete in Nabi's first NicVAX Phase III clinical trial for nicotine addiction

Mylan subsidiary receives FDA final approval for Nabumetone Tablets ANDA

KRX-0401 receives Orphan Drug designation from FDA for treatment of neuroblastoma

SWCRF/Emerald Foundation Global Collaborative Grant to fund critical cancer research

Concert Medical releases 'Conductor' family of Interventional Coronary Guidewires in U.S.

Research: Early diagnosis, care management for people with dementia can lower outpatient costs by 30%

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News